Key Points

- Humana's stock falls after a cut in its Medicare Advantage rating by the Centers for Medicare and Medicaid Services
- Concerns rise over the impact on the company's Medicare Advantage program
- Humana reports a decline in the total members enrolled in its highly rated Medicare Advantage plans for 2025
- The news results in a 12% drop in Humana's shares during premarket trading
- Investors react to the downgrade by selling off shares, causing the stock to hit a more than four-year low

Humana's stock experienced a significant decline in value on Tuesday following a rating cut from the Centers for Medicare and Medicaid Services on one of its large Medicare Advantage plans. The government's decision to lower the rating was due to the plan missing certain performance measures, leading to concerns about the overall stability of Humana's Medicare Advantage program.

As a result of the downgrade, Humana reported a decrease in the total number of members enrolled in its highly rated Medicare Advantage plans for individuals aged 65 and above. This announcement caused a sharp selloff in the insurer's shares, with the stock falling by approximately 12% during premarket trading.

Investors reacted swiftly to the news, selling off their shares in response to the lower rating and reduced enrollment numbers. This selling pressure caused Humana's stock to hit a more than four-year low, signaling growing uncertainty about the future prospects of the company's Medicare Advantage business.

The rating cut from the Centers for Medicare and Medicaid Services has raised concerns about the long-term viability of Humana's Medicare Advantage program. The decline in both the rating and enrollment numbers has put additional pressure on the company's stock, leading to increased market volatility.

Overall, Humana's stock took a significant hit after receiving a lower rating on one of its Medicare Advantage plans and reporting a decrease in total enrollment for 2025. Investors are closely watching the situation as worries mount about the impact of these developments on the company's financial performance and future growth prospects.

About HUM

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

For more information:

Up/Down Rally

Price Distribution

Analyst Recommendations

Earning Price Impact Analysis

Seasonality